RXST RxSight, Inc.

8-K Current Report

Filed: March 19, 2026

Health Care

Ophthalmic Goods

RxSight, Inc. (RXST) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 5.02: Departure/Election of Directors or Officers

AI Filing Analysis
8-K

Item 5.02 · Departure/Election of Directors or Officers

• CFO Mark Wilterding received $169,348.10 sign-on bonus paid March 13, 2026, per employment agreement
• Stock option vesting corrected: 25% after 1 year, remaining monthly over 3 years, fully vested after 4 years from Jan 11, 2026

+2 more insights

Other RxSight, Inc. 8-K Filings

8-K Feb 25, 2026

Get deeper insights on RxSight, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.